Sustained virological response after 8-week treatment of simeprevir with peginterferon α-2a plus ribavirin in a Japanese female with Hepatitis C virus genotype 1b and IL28B minor genotype

Case Reports in Gastroenterology

Volumn 9, Issue , 2015, Pages 215-220

  Kanda, Tatsuo ^a   Nakamura, Masato ^a   Sasaki, Reina ^a   Yasui, Shin ^a   Nakamoto, Shingo ^a   Haga, Yuki ^a   Jiang, Xia ^a   Wu, Shuang ^a   Tawada, Akinobu ^a   Arai, Makoto ^a   Imazeki, Fumio ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Peginterferon; Ribavirin; Simeprevir; Sustained virological response

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; DOMPERIDONE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; INTERLEUKIN 28B; INTERLEUKIN 28B MINOR GENOTYPE; LOXOPROFEN; PEGINTERFERON ALPHA2A; RIBAVIRIN; SIMEPREVIR; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE REPORT; CHILD PUGH SCORE; CHOLESTEROL BLOOD LEVEL; CHRONIC HEPATITIS C; CLINICAL PRACTICE; ECHOGRAPHY; ELASTOGRAPH; ELASTOGRAPHY; FATIGUE; FEMALE; FEVER; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; JAPAN; JAPANESE (PEOPLE); LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LOSS OF APPETITE; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; SIDE EFFECT; SPLENOMEGALY; THROMBOCYTE COUNT; TONGUE CANCER; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

EID: 84941951791     PISSN: None     EISSN: 16620631     Source Type: Journal    
DOI: 10.1159/000437138     Document Type: Article

References (8)

1. Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26(3 suppl 1): 34S-38S
2. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549
3. Akamatsu N, Sugawara Y: Living-donor liver transplantation and hepatitis C. HPB Surg 2013; 2013: 985972
4. Wu S, Kanda T, Nakamoto S, Miyamura T, Nakatani SM, Ono SK, Takahashi-Nakaguchi A, Gonoi T, Yokosuka O: Prevalence of hepatitis C virus subgenotypes 1a and 1b in Japanese patients: ultra-deep sequencing analysis of HCV NS5B genotype-specific region. PLoS One 2013; 8: e73615
5. Kanda T, Imazeki F, Yokosuka O: New antiviral therapies for chronic hepatitis C. Hepatol Int 2010; 4: 548-561
6. Fried MW, Buti M, Dore GJ, Flisiak R, Ferenci P, Jacobson I, Marcellin P, Manns M, Nikitin I, Poordad F, Sherman M, Zeuzem S, Scott J, Gilles L, Lenz O, Peeters M, Sekar V, De Smedt G, Beumont-Mauviel M: Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study. Hepatology 2013; 58: 1918-1929
7. Stine JG, Intagliata N, Shah NL, Argo CK, Caldwell SH, Lewis JH, Northup PG: Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis. Dig Dis Sci 2014; 60: 1031-1035
8. Suzuki Y, Miwa S, Shirai M, Ohba H, Murakami M, Fujita K, Suda T, Nakamura H, Hayakawa H, Chida K: Drug lymphocyte stimulation test in the diagnosis of adverse reactions to antituberculosis drugs. Chest 2008; 134: 1027-1032